Sera Prognostics (SERA) Other Non-Current Assets (2020 - 2026)
Sera Prognostics' (SERA) quarterly Other Non-Current Assets came in at $2.5 million in Q1 2026, up 321.09% YoY from $588000.0 in Q1 2025, and down 1.94% on a QoQ basis from $2.5 million in Q4 2025.
Sera Prognostics (SERA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Other Non-Current Assets data on file, last reported at $2.5 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 321.09% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 321.09% YoY) and the FY2025 annual result came in at $2.5 million, up 242.61% from the prior year.
- Other Non-Current Assets fell to $2.5 million in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.6 million in Q3 2025 to a low of $237000.0 in Q3 2022.
- A 5-year average of $1.4 million and a median of $1.5 million in 2023 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 1056.69% in 2022, down 87.16% in 2022.
- Tracing SERA's Other Non-Current Assets over 5 years: stood at $1.8 million in 2022, then tumbled by 30.78% to $1.3 million in 2023, then slumped by 41.37% to $737000.0 in 2024, then jumped by 242.61% to $2.5 million in 2025, then retreated by 1.94% to $2.5 million in 2026.
- The last three Other Non-Current Assets figures came in at $2.5 million (Q1 2026), $2.5 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Sera Prognostics | 108.53 Mn | 108.53 Mn | -20,000.00 | 2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.48 Mn |
| Mar 31, 2026 | 2.48 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 435,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 737,000.00 |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.82 Mn |
| Sep 30, 2022 | 237,000.00 |
| Jun 30, 2022 | 363,000.00 |
| Mar 31, 2022 | 487,000.00 |
| Dec 31, 2021 | 157,000.00 |
| Sep 30, 2021 | 168,000.00 |